CrushSCI.com
177.6Average days
159Median days
110Fastest days
347Longest days
4672025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

165 days

PCSK9 as a mediator of monocytes transendothelial activation in obstructive sleep apnoea: A translational study

Authors
Marc-Adrien Reveyaz; Yann Sibaud; Maël Brossette; Alejandro Arco-Hierves; Antoine Boutin; Emeline Lemarié; Jonathan Gaucher; Van Ngo; Marie Joyeux-Faure; Sébastien Bailly; Renaud Tamisier; Jean-Louis Pépin; Gilles Faury; Anne Briançon-MarjolletShow moreShow less
Affiliations
Univ. Grenoble Alpes, INSERM, HP2 Laboratory, 38000, Grenoble, FranceShow moreShow less
Source PDF DOI Publisher page
186 days

Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation

Authors
Lingyan Jin; Tiannan Jiang; Haoyu Gong; Lulu Gong; Yizhen Wang; Ziwei Chen; Peng Liu; Xinghua Qin; Qiangsun ZhengShow moreShow less
Affiliations
Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China; School of Life Science and Technology, Northwestern Polytechnical University, Xi'an, Shaanxi, China; Research Center for Prevention and Treatment of Respiratory Disease, School of Clinical Medicine, Xi'an Medical University, Xi'an, Shaanxi, ChinaShow moreShow less
Source PDF DOI Publisher page
158 days

MX1 promotes gastric cancer cell migration via inhibiting ANXA2 ubiquitination and degradation

Authors
Hang Yang; Huihan Ai; Zikun Wu; Guanglong Chen; Weijie Zhao; Banghe Bao; Chai Luv; Wenpu Zhu; Faqiang Liu; Kangdong Liu; Zhi LiShow moreShow less
Affiliations
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450008, China; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China; China-US Hormel (Henan) Cancer Institute, Zhengzhou, Henan, ChinaShow moreShow less
Source PDF DOI Publisher page
270 days

Repurposing Nelfinavir: AIM2 inflammasome-associated anti-tumor effects in Glioblastoma

Authors
Durgesh Meena; Lipika Sha; Shalini Chhipa; Priya Solanki; Sushmita JhaShow moreShow less
Affiliations
Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, 342037, IndiaShow moreShow less
Source PDF DOI Publisher page
110 days

Hepatic methionine-cycle dysregulation is associated with immune-inflammatory and fibrogenic remodeling in biliary atresia

Authors
Chao Lv; Xiaoke Dai; Haoming Wang; Xiaolei Gao; Bingqian Tan; Chenyu Yang; Yao Zhao; Mingman ZhangShow moreShow less
Affiliations
Department of Hepatobiliary Surgery Children's Hospital of Chongqing Medical University, National Key Clinical Specialty Project, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, 400000, ChinaShow moreShow less
Source PDF DOI Publisher page
121 days

USP53-ALKBH5 axis inhibition boosts m6A-modified TERT RNA degradation: A potential therapeutic strategy for glioblastoma

Authors
Guihong Li; Ting Lei; Erpeng Liu; Jing Shen; Dun Liu; Xuqiang ZhuShow moreShow less
Affiliations
Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450000, People's Republic of China; Department of Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450000, People's Republic of China; Department of Cardiopulmonary Function, Henan Provincial Chest Hospital, No.1 Weiwu Road, Jinshui District, Zhengzhou, Henan Province, 450000, People's Republic of ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.